GPC3 and neoplasm: Therefore, the near-zero expression of GPC3 in normal tissues, low expression in LUAD, and high expression in LUSC led us to hypothesize that GPC3 plays a role in immunotherapy as a tumor-associated antigen of LUSC and becomes a reasonable immunotherapeutic target for LUSC.